Simeprevir
Simeprevir[edit | edit source]
Simeprevir is an antiviral drug used in the treatment of hepatitis C, a viral infection that affects the liver. It is classified as a protease inhibitor, specifically targeting the NS3/4A protease of the hepatitis C virus (HCV). Simeprevir is used in combination with other medications to enhance its efficacy in clearing the virus from the body.
Mechanism of Action[edit | edit source]
Simeprevir works by inhibiting the NS3/4A protease, an enzyme critical for the replication of the hepatitis C virus. By blocking this enzyme, simeprevir prevents the virus from multiplying, thereby reducing the viral load in the patient's body. This action helps in the clearance of the virus when used in combination with other antiviral agents.
Clinical Use[edit | edit source]
Simeprevir is indicated for use in adults with chronic hepatitis C infection, particularly those with genotype 1. It is often used in combination with other antiviral drugs such as sofosbuvir or ribavirin, and sometimes with peginterferon alfa. The combination therapy is tailored based on the patient's specific genotype and liver function status.
Administration and Dosage[edit | edit source]
Simeprevir is administered orally, typically once daily. The dosage and duration of treatment depend on the combination regimen and the patient's response to therapy. It is important for patients to adhere to the prescribed regimen to achieve optimal results.
Side Effects[edit | edit source]
Common side effects of simeprevir include rash, photosensitivity, pruritus, and nausea. Patients are advised to avoid excessive sun exposure and to use protective measures such as sunscreen and clothing. Serious side effects are rare but can include liver dysfunction and allergic reactions.
Drug Interactions[edit | edit source]
Simeprevir can interact with other medications, particularly those metabolized by the cytochrome P450 enzyme system. It is important for healthcare providers to review a patient's medication list to avoid potential interactions that could affect the efficacy or safety of the treatment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
